8-aminoadenosine has been researched along with Granulocytic Leukemia, Chronic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ayres, ML; Chen, LS; Gandhi, V; Keating, MJ; Nowak, BJ; Pillai, RN; Shpall, EJ; Thomas, MW | 1 |
| Frankfurt, O; Platanias, LC | 1 |
2 other study(ies) available for 8-aminoadenosine and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Multifaceted actions of 8-amino-adenosine kill BCR-ABL positive cells.
Topics: Adenosine; Adenosine Triphosphate; Antineoplastic Agents; Apoptosis; Benzamides; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Gene Expression Regulation, Leukemic; Humans; Imatinib Mesylate; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Transcription, Genetic | 2012 |
Non-tyrosine kinase inhibitor-targeting of BCR-ABL expressing cells.
Topics: Adenosine; Fusion Proteins, bcr-abl; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2012 |